Biolase (BIOL) Tops Q2 EPS by 5c

Biolase (NASDAQ: BIOL) reported Q2 EPS of ($0.12), $0.05 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $2.9 million versus the consensus estimate of $2.09 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Logistic Properties of the Americas (LPA) Reports Q2 results
• Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02